RSLS
ReShape Lifesciences Inc.
-48.86%
$5.91 - $3.02
Feb 8th 2023 - Mar 22nd 2023
Feb, 22, 2023
$RSLS shows a strong growth in Revenue.
Feb, 18, 2023
$RSLS: The Revenue has been growing by 32.01% on a... See more
BBAI
BigBear.ai Holdings Inc
-61.99%
$4.92 - $1.87
Feb 7th 2023 - Mar 21st 2023
Mar, 16, 2023
Revenue grow year after year so this company can&#... See more
Mar, 14, 2023
This company grow revenue year after year and posi... See more
Feb, 22, 2023
$RSLS shows a strong growth in Revenue.
Feb, 18, 2023
$RSLS: The Revenue has been growing by 32.01% on average over the past 5 years.
Feb, 8, 2023
$RSLS: The Revenue has been growing by 32.01% on average over the past 5 years.
Feb, 3, 2023
$RSLS: The Revenue has been growing by 32.01% on average over the past 5 years.
Feb, 4, 2023
$TGTX shows a strong growth in Revenue.
Feb, 3, 2023
$TGTX shows a strong growth in Revenue.
Jan, 29, 2023
Add beginning revenue stream, BO rumors, a steady stream of upgrades.
Dec, 30, 2022
$TGTX This gonna be amazing guys after they sell their product Lets say 50.000 usd for the dose and they sell 500 a month Make the math and tell me how revenue they will get every quarter
Dec, 30, 2022
$TGTX $KALA $HOTH $NUWE TGTX on fire 🔥 and solid from fundamentals perspective after yesterday FDA approval of Multiple Sclerosis Billion dollar drug revenue potential.
Dec, 30, 2022
This is not some get rich scheme, this is a solid biotech company with an approved product that will bring in billions in revenue.
Mar, 16, 2023
Revenue grow year after year so this company can't bankrupt in any condition of national economy.
Mar, 14, 2023
This company grow revenue year after year and positive cash flow second half this year.
Mar, 14, 2023
Also, significant bottom line improvements YoY.
Mar, 14, 2023
$BBAI Nice job on revenues.
Mar, 13, 2023
$BBAI YoY numbers are great for a small company.
Mar, 2, 2023
I like the revenue growth and the greatly improving profitability! !
Feb, 28, 2023
$IVDA Has diverse AI revenue streams and have all the technology and devices to support a full Smart City.
Feb, 12, 2023
They are light years ahead of every single AI play and have diverse revenue streams to support ORGANIC GROWTH.
Feb, 12, 2023
$IVDA is diverse in its revenue streams, Ivedacare as a product line for $BBAI $SOUN $AI $FOXO would be far superior to any of their AI components,
Feb, 9, 2023
$BBAI $GFAI $SOUN $AI $IVDA is the only AI stock that people should be buying now, this has a significant upside, smart city innovator, several AI revenue streams and projecting profitability this year.